Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Lucia Damicis"'
Publikováno v:
Targeted Oncology
Cabozantinib is an oral multikinase inhibitor whose targets include vascular endothelial growth factor receptors, MET, and the TAM family of kinases (TYRO3, AXL, MER). Cabozantinib is approved for patients with advanced hepatocellular carcinoma who h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32990a656b391bee272364b8985dda1f
https://doi.org/10.1007/s11523-020-00736-8
https://doi.org/10.1007/s11523-020-00736-8
Autor:
Rossella Elisei, Rudy Foddis, Federica Gnudi, M. Cipollini, Gisella Figlioli, Chiara De Santi, Federica Gemignani, Lucia Damicis, Alessandra Bonotti, Roberto Barale, Alice Cecchini, Francesca De Paola, Alfonso Cristaudo, Giovanni Pellegrini, Cristina Romei, Debora Landi, Tania Frixa, Lisa Cancemi, Sonia Garritano, Stefano Landi, Ombretta Melaiu, Simona Bramante, Loredana Maiorano
Background: Genome-wide association studies have shown that the 8q24 region harbours multiple independent cancer susceptibility loci and it was also defined as the “susceptibility cancer region.” Thus, it could be hypothesized that genetic varian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d503acd2a2166e1373b5522a6624b443
http://hdl.handle.net/2108/305979
http://hdl.handle.net/2108/305979
